Cartalax
Cartalax (Ala-Glu-Asp) is a specialized Khavinson tripeptide bioregulator acting as the absolute foundational bedrock for extreme cartilage and joint regeneration. While BPC-157 relies on angiogenesis to heal connective tissue, Cartalax operates on a strictly epigenetic layer to rebuild the joint matrix from the inside out. It is aggressively prescribed in advanced functional protocols to halt brutal age-related osteoarthritis, rapidly heal catastrophic ligament tears, and forcibly stimulate the regrowth of worn cartilage surfaces in high-impact athletes.
Quick Stats
Scientific Data
Mechanism of Action
Cartalax (Ala-Glu-Asp) is a tripeptide bioregulator targeting cartilage and connective tissue gene expression. It promotes chondrocyte activity, collagen synthesis, and cartilage matrix protein production. Khavinson studies demonstrate improved cartilage regeneration and joint function in animal models and elderly patients with osteoarthritis.
Source: PMID: 15677927
Background & History
Cartalax (Ala-Glu-Asp) is the synthetic cartilage bioregulator, targeting chondrocyte gene expression for proteoglycan and collagen type II synthesis.
Research Use Cases
- ✓Osteoarthritis support
- ✓Cartilage maintenance in aging
- ✓Joint health protocols
Dosing Protocol
| Typical Dose | 10-20 mg/day (oral) or 1-2 mg SC |
| Frequency | 1× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
| Common Vial Sizes | 5 mg, 10 mg |
Dosing Protocols
Khavinson Protocol
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 1000–20000 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 771 mcg | 8100 mcg | 15429 mcg |
| 140 lb(63 kg) | 900 mcg | 9450 mcg | 18000 mcg |
| 160 lb(73 kg) | 1043 mcg | 10950 mcg | 20857 mcg |
| 180 lb(82 kg) | 1171 mcg | 12300 mcg | 23429 mcg |
| 200 lb(91 kg) | 1300 mcg | 13650 mcg | 26000 mcg |
| 220 lb(100 kg) | 1429 mcg | 15000 mcg | 28571 mcg |
| 250 lb(113 kg) | 1614 mcg | 16950 mcg | 32286 mcg |
💉 For exact syringe units based on your vial concentration, use the Cartalax Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Cartilage / Joint Aging
LowCartilage-specific bioregulator. Restores chondrocyte gene expression and collagen synthesis in aging joints.
Reconstitution Example
Safety & Considerations
Research peptide. Extensively used in Russian clinical protocols. Excellent safety profile in elderly populations.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Standard Khavinson protocol.
Synergies & Common Stacks
Cartalax (synthetic tripeptide) + Sigumir (cartilage/bone Cytomax extract) = layered musculoskeletal support.
Dosing Quick Reference
Frequently Asked Questions
How does Cartalax help cartilage?▼
References
- Khavinson VKh et al. “"Short peptide bioregulators for cartilage aging".” Bulletin of Experimental Biology and Medicine (2009). PMID: 19503960
📚 Related Articles
Get Cartalax from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.
Affiliate link · Full review